Related references
Note: Only part of the references are listed.Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Erik H. J. G. Aarntzen et al.
CLINICAL CANCER RESEARCH (2013)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein
S. Bobadilla et al.
GENE THERAPY (2013)
Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial
Eliane C. M. Zeestraten et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A Dendritic Cell-Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
Felipe Garcia et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
Lana E. Kandalaft et al.
ONCOIMMUNOLOGY (2013)
Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques
Maximillian Rosario et al.
AIDS (2012)
Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates
Marcin Kwissa et al.
BLOOD (2012)
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
Lauren J. Bayne et al.
CANCER CELL (2012)
Harnessing human plasmacytoid dendritic cells as professional APCs
Jurjen Tel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
Peggy J. de Vos van Steenwijk et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
Paul Sabbatini et al.
CLINICAL CANCER RESEARCH (2012)
Conference Scene: Immune effector mechanisms in tumor immunity
Andrew G Sikora et al.
Immunotherapy (2012)
HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44
Davor Frleta et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer
Shinichi Fujiwara et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Immunomodulating antibodies in the treatment of metastatic melanoma: The experience with anti-CTLA-4, anti-CD137, and anti-PD1
Ester Simeone et al.
JOURNAL OF IMMUNOTOXICOLOGY (2012)
Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity
C. Trumpfheller et al.
JOURNAL OF INTERNAL MEDICINE (2012)
Recent Advances in Intravital Imaging of Dynamic Biological Systems
Junichi Kikuta et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
IL-12 family cytokines: immunological playmakers
Dario A. A. Vignali et al.
NATURE IMMUNOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
How vitamin A metabolizing dendritic cells are generated in the gut mucosa
William W. Agace et al.
TRENDS IN IMMUNOLOGY (2012)
Interleukin-15 biology and its therapeutic implications in cancer
Jason C. Steel et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice
Bei Wang et al.
BREAST CANCER RESEARCH (2012)
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation
Eric Lutz et al.
ANNALS OF SURGERY (2011)
A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
Sarah M. Rudman et al.
CLINICAL CANCER RESEARCH (2011)
Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
Emanuela Romano et al.
CLINICAL CANCER RESEARCH (2011)
Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
W. Joost Lesterhuis et al.
CLINICAL CANCER RESEARCH (2011)
Interleukin 15 as a promising candidate for tumor immunotherapy
Marek Jakobisiak et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Inhibitory C-type lectin receptors in myeloid cells
Pierre Redelinghuys et al.
IMMUNOLOGY LETTERS (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
Juliana Idoyaga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody
Cheolho Cheong et al.
BLOOD (2010)
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells
Nadine Pouw et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
Jean-Pierre Routy et al.
CLINICAL IMMUNOLOGY (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
In Vivo Role of Flt3 Ligand and Dendritic Cells in NK Cell Homeostasis
Martin Guimond et al.
JOURNAL OF IMMUNOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CD8+T Cell Priming by Dendritic Cell Vaccines Requires Antigen Transfer to Endogenous Antigen Presenting Cells
Alice W. Yewdall et al.
PLOS ONE (2010)
Prostaglandin E2 enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells
Petra Krause et al.
BLOOD (2009)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer
Alessandra Battaglia et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Inhibition of Transforming Growth Factor-β-Mediated Immunosuppression in Tumor-Draining Lymph Nodes Augments Antitumor Responses by Various Immunologic Cell Types
Takuya Fujita et al.
CANCER RESEARCH (2009)
Cytokine gene-mediated immunotherapy: Current status and future perspectives
Masahisa Jinushi et al.
CANCER SCIENCE (2009)
Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Pauline Verdijk et al.
CLINICAL CANCER RESEARCH (2009)
Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
Frank M. Speetjens et al.
CLINICAL CANCER RESEARCH (2009)
Sensing pathogens and danger signals by the inflammasome
Joao H. F. Pedra et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb
Oihana Murillo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Improving vaccines by targeting antigens to dendritic cells
Ken Shortman et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges
Madhav V. Dhodapkar
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines
Eynav Klechevsky et al.
HUMAN IMMUNOLOGY (2009)
Immune regulation by 4-1BB and 4-1BBL: complexities and challenges
Chao Wang et al.
IMMUNOLOGICAL REVIEWS (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial
Ninke Leffers et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor β-Expressing T Cells
Mercedes N. Lopez et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Karl S. Peggs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Chemotherapeutic Agents in Noncytotoxic Concentrations Increase Antigen Presentation by Dendritic Cells via an IL-12-Dependent Mechanism
Galina V. Shurin et al.
JOURNAL OF IMMUNOLOGY (2009)
Suppressive Influences in the Immune Response to Cancer
Vincenzo Bronte et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations
Ramon Kaneno et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Human Papillomavirus Type 16 (HPV-16) Virus-Like Particle L1-Specific CD8+ Cytotoxic T Lymphocytes (CTLs) Are Equally Effective as E7-Specific CD8+ CTLs in Killing Autologous HPV-16-Positive Tumor Cells in Cervical Cancer Patients: Implications for L1 Dendritic Cell-Based Therapeutic Vaccines
Stefania Bellone et al.
JOURNAL OF VIROLOGY (2009)
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia.
Gemma G. Kenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
Rajesh T. Gandhi et al.
VACCINE (2009)
C-type lectins on dendritic cells: key modulators for the induction of immune responses
Yvette van Kooyk
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement
Irina Caminschi et al.
BLOOD (2008)
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
A. C. Inge Boullart et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Dendritic cells dysfunction in tumour environment
Karim Bennaceur et al.
CANCER LETTERS (2008)
Type 2 Bias of T Cells Expanded from the Blood of Melanoma Patients Switched to Type 1 by IL-12p70 mRNA-Transfected Dendritic Cells
Kira Minkis et al.
CANCER RESEARCH (2008)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows lowtoxicity and robust immunogenicity
Gemma G. Kenter et al.
CLINICAL CANCER RESEARCH (2008)
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission
Catherine S. M. Diefenbach et al.
CLINICAL CANCER RESEARCH (2008)
Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies
Raanan Berger et al.
CLINICAL CANCER RESEARCH (2008)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Promises and challenges for the development of Listeria monocytogenes-based immunotherapies
Dirk G. Brockstedt et al.
EXPERT REVIEW OF VACCINES (2008)
Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines
Masahisa Jinushi et al.
IMMUNOLOGICAL REVIEWS (2008)
Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses
Sandra J. van Vliet et al.
IMMUNOLOGY AND CELL BIOLOGY (2008)
KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity
Mojca Skoberne et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells
Javier Carrasco et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
Sylvia Adams et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients
Julien Fourcade et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
Bruce G. Redman et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Adenovirus MART-1 - engineered autologous dendritic cell vaccine for metastatic melanoma
Lisa H. Butterfield et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
Je-Jung Lee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Engineered lentivector targeting of dendritic cells for in vivo immunization
Lili Yang et al.
NATURE BIOTECHNOLOGY (2008)
The Foxp3(+) regulatory T cell: a jack of all trades, master of regulation
Qizhi Tang et al.
NATURE IMMUNOLOGY (2008)
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
Jianda Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
Pierre Vandepapeliere et al.
VACCINE (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) - A novel strategy for the treatment of melanoma and other malignancies
Steven J. O'Day et al.
CANCER (2007)
Recombinant lentivector as a genetic immunization vehicle for antitumor immunity
Yukai He et al.
EXPERT REVIEW OF VACCINES (2007)
Balancing between immunity and tolerance: An interplay between dendritic cells, regulatory T cells, and effector T cells
Nathalie Cools et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation:: enhanced T cell stimulatory capacity despite IDO
Petra Krause et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes
Gianni Gerlini et al.
CLINICAL IMMUNOLOGY (2007)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics
K. Breckpot et al.
GENE THERAPY (2007)
Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2
Philippe Veron et al.
JOURNAL OF VIROLOGY (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
Brian J. Czerniecki et al.
CANCER RESEARCH (2007)
Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity
Anna K. Palucka et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1
Robert W. Carter et al.
JOURNAL OF IMMUNOLOGY (2006)
The apoptotic-cell receptor CR3, but not ανβ5, is a regulator of human dendritic-cell immunostimulatory function
Mojca Skoberne et al.
BLOOD (2006)
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
Tobias Warger et al.
BLOOD (2006)
Combination therapy with anti-CTL antigen-4 and anti-4-1BB antibodies enhances cancer immunity and reduces autoimmunity
Ergun Kocak et al.
CANCER RESEARCH (2006)
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
C Blank et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Defective human leukocyte antigen class I-associated antigen presentation caused by a novel β2-microglobulin loss-of-function in melanoma cells
Chien-Chung Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
M Salcedo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
H Kato et al.
NATURE (2006)
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells
SA Rosenberg et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma:: a randomized phase III trial of the DC study group of the DeCOG
D Schadendorf et al.
ANNALS OF ONCOLOGY (2006)
Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors
M Dullaers et al.
GENE THERAPY (2006)
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
SB Boscardin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors
RM Teague et al.
NATURE MEDICINE (2006)
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens
P Baumgaertner et al.
CANCER RESEARCH (2006)
Induction of CD8+ T cell responses through targeting of antigen to Dectin-2
Robert W. Carter et al.
CELLULAR IMMUNOLOGY (2006)
Dendritic cells, pulsed with lysate of allogeneic tumor cells, are capable of stimulating MHC-restricted antigen-specific antitumor T cells
R Mahdian et al.
MEDICAL ONCOLOGY (2006)
Targeting antigens to dendritic cells in vivo
Paul J. Tacken et al.
IMMUNOBIOLOGY (2006)
Th1-polarizing capacity of clinical-grade dendritic cells is triggered by ribomunyl but is compromised by PGE2 -: The importance of maturation cocktails
W Jongmans et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody
PJ Tacken et al.
BLOOD (2005)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help
MA Kutzler et al.
JOURNAL OF IMMUNOLOGY (2005)
A critical function for type I interferons in cancer immunoediting
GP Dunn et al.
NATURE IMMUNOLOGY (2005)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
DH Chang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery
M Schnurr et al.
BLOOD (2005)
Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity
YK He et al.
JOURNAL OF IMMUNOLOGY (2005)
Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells
C Munz et al.
BLOOD (2005)
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas
JL Marshall et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
MK Levings et al.
BLOOD (2005)
Plasmacytoid dendritic cells: Linking innate and adaptive immunity
K McKenna et al.
JOURNAL OF VIROLOGY (2005)
Drug-induced increase of carcinoembryonic antigen expression in cancer cells
A Aquino et al.
PHARMACOLOGICAL RESEARCH (2004)
Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells
G Lizée et al.
HUMAN GENE THERAPY (2004)
Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules
V Ramakrishna et al.
JOURNAL OF IMMUNOLOGY (2004)
Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells
MR Müller et al.
BLOOD (2004)
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T Cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Identification of new antigenic peptide presented by HLA-Cw7 and encoded by several MAGE genes using dendritic cells transduced with lentiviruses
K Breckpot et al.
JOURNAL OF IMMUNOLOGY (2004)
α-type-1 polarized dendritic cells:: A novel immunization tool with optimized CTL-inducing activity
RB Mailliard et al.
CANCER RESEARCH (2004)
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
W Lu et al.
NATURE MEDICINE (2004)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Danger signals: a time and space continuum
M Skoberne et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix
FE Baratelli et al.
JOURNAL OF IMMUNOLOGY (2004)
Cancer immunotherapy with mRNA-transfected dendritic cells
E Gilboa et al.
IMMUNOLOGICAL REVIEWS (2004)
IDO and tolerance to tumors
DH Munn et al.
TRENDS IN MOLECULAR MEDICINE (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
B Barrou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Regulation of dendritic cell migration to the draining lymph node:: Impact on T lymphocyte traffic and priming
A Martín-Fontecha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Antigen loading of dendritic cells with whole tumor cell preparations
P Thumann et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Treatment of colon and breast carcinoma cells with 5-fluorouracil enhances expression of carcinoembryonic antigen and susceptibility to HLA-A(*)02.01 restricted, CEA-peptide-specific cytotoxic T cells in vitro
P Correale et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions
M Salio et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer
A Nencioni et al.
CANCER GENE THERAPY (2003)
Dendritic cells under the spell of prostaglandins
AE Morelli et al.
TRENDS IN IMMUNOLOGY (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA
C Milazzo et al.
BLOOD (2003)
Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation
S Nair et al.
JOURNAL OF IMMUNOLOGY (2003)
A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells:: implications for immunotherapy
AW Lee et al.
VACCINE (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs
S Fujii et al.
NATURE IMMUNOLOGY (2002)
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody
AP Vicari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived denctritic cells
E Scandella et al.
BLOOD (2002)
Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans
MV Dhodapkar et al.
BLOOD (2002)
Mobilization of dendritic cell precursors in patients with cancer by Flt3 ligand allows the generation of higher yields of cultured dendritic cells
CE Marroquin et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-Transfected dendritic cells
SK Nair et al.
ANNALS OF SURGERY (2002)
Toll-like receptors control activation of adaptive immune responses
M Schnare et al.
NATURE IMMUNOLOGY (2001)
Viral vectors for dendritic cell-based immunotherapy
L Jenne et al.
TRENDS IN IMMUNOLOGY (2001)
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes
J Dyall et al.
BLOOD (2001)
Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes
I Strobel et al.
GENE THERAPY (2000)
Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
JL Marshall et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA
S Koido et al.
JOURNAL OF IMMUNOLOGY (2000)
Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
H Jonuleit et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo
KS Schluns et al.
NATURE IMMUNOLOGY (2000)
Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo
B Pulendran et al.
JOURNAL OF IMMUNOLOGY (2000)
Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system
R Schroers et al.
MOLECULAR THERAPY (2000)
Share Paper
